Page 183 - CW E-Magazine (19-11-2024)

CPHI MILAN 2024 CPHI MILAN 2024

Award’ went to Mr. Guy Clark, CEO, delivering medication in the form of a Acu-Flo’s new category of nebu- ceutical ingredients (APIs) or excipients,
CNX Therapeutics. He led the com- straw that dissolves in drinking water lisers for overcoming challenges in besides other applications like chromato-
pany’s transformation from a single- or beverages – was adjudged the the respiratory drug delivery received graphic separation, diagnostics, nanopar-
product loss-making, non-core busi- winner in the ‘Finished Formulation’ the ‘Start-Up Initiative Award’. ticle milling, and biocatalysis. Purolite
ness unit into a standalone entity with category. Ecolab has more than four decades of
£50-mn in revenues and a portfolio of In the ‘Supply Chain Excellence’, experience manufacturing APIs, such as
over 20 products sold in over 50 coun- In the ‘Manufacturing Excellence’ it was QYOBO GmbH who scooped cholestyramine and sodium polystyrene
tries worldwide. category, RheaVita’s RheaLyo GMP- the top award for a platform that pro- sulfonate and excipients. These applica-
fl ex continuous freeze-drying system vides crucial insights into global sup- tions are vital to time-release formulas
In the ‘API Development and that allows aseptic GMP production ply chains to help companies identify, and enhanced drug bioavailability.
Innovation’ category, the judges of biopharmaceuticals was awarded manage, and anticipate supply risks.
selected Lonza for its AI-enabled top marks. “COVID made us realise that pharma
route scouting service. This crystalises In the ‘Sustainability Award’ cate- customers want to have multiple sources
the company’s advanced, data-driven The ‘Cere Screen Digital Display gory it was Evonik Industries who of supply for their APIs and excipients. In
approach to retrosynthetic analysis Label’ from Smurfi t WestRock was came out on top for their PhytoSquene the past, we supplied from our Romanian
for designing optimal synthesis routes the winner in the ‘Packaging and plant-based squalene for parenteral plant. Now with our US plant in commer-
for small molecule APIs. It uses Machinery’ category as it seamlessly applications. cial operation, our pharma customers can
AI-enabled predictive tools that com- integrates digital screens into clinical have shortened lead times and security of Indian market ness and so the majority of our resins
bine theoretical retrosynthesis with trial investigational medicinal product West Pharmaceutical Services got supply to enable them to develop & deli- Quizzed on the growth prospects in are sold to pharmaceutical and biotech
supply chain intelligence to identify packaging, ushering in a new era of the ‘Heart of Pharma’ award for its ver life-saving drugs faster,” said Mr. Pan. the Indian market, Mr. Pan pointed to customers,” he observed.
commercially viable routes. information-rich labelling. collaboration with the Fox Chase the recent visit of Ecolab’s CEO
Cancer Center (FCCC) in the deli- Speaking about pharma market Mr. Christophe Beck to India and his Mr. Pan said while the local team in
In the ‘Drug Delivery and Device In the ‘Regulatory and Compli- very of cancer screenings to residents trends, Mr. Pan highlighted signifi cant bullish outlook on the country. India struggled in the past due to the sin-
Innovation’, an effective treatment for ance’ category, Prodigy from Pro- of Pennsylvania (USA) via a mobile innovation work being focused on drug gle source of supply from Romania and
tremors and other uncontrolled body Pharma Group was judged to be the screening unit (MSU). delivery systems. “Complex delivery “Our CEO believes that India is in- its limited supply capacities, the King
movements associated with certain best entry. Prodigy comprises a suite properties like taste masking, controlled vesting heavily in areas of life-tech, high- of Prussia plant has helped address this
neurological conditions developed of AI and advanced automation appli- AustinPx received the ‘Accelerat- release, abuse deterrence, etc., need inno- tech and clean-tech and keen on attract- issue. “We are also building a new plant
by Adare Pharma Solutions was the cations that solve productivity chal- ing Innovation Award’ for its KinetiSol vations in excipients, and that’s where ing top companies to invest. We also have in China, which will partially produce
winner. lenges that can cause delays and incur technology – a fusion-based, solvent- we have a lot of conversations with our our own investments in India and we are some raw materials for the excipient
costs throughout the pharmaceutical free process designed to address the pharmaceutical customers on undertak- looking as to how we can position our- business. We plan to have our US plant
Unistraw’s ‘UniLayer Straw Deli- and medical device development life- increasing challenge of poor drug solu- ing joint innovations,” he said. selves in India smartly to leverage our supply all our US and India customers,
very System’ – an innovative way of cycle. bility in the pharmaceutical industry. investments and grow in life sciences with Romania supporting the rest of the
“We are also expanding applica- and high-tech areas,” he said. markets,” he said.
ION EXCHANGE RESINS tions in line with new market trends and
expectations, especially in controlled As for pharmaceutical/life-tech, he “We believe India is set to get bigger
Ecolab banking on new US facility to ensure security substances abuse deterrent. We are also noted that India is one of the fastest as a market and getting embedded into
stepping into nutraceuticals and helping growing markets for both the bio-process its ecosystem is one of our priorities. We
of supply to pharma customers this industry leverage our technology business and traditional pharmaceuticals. defi nitely see India as our most important
and engage in development work as “Our Indian team has been traditionally market for growth for pharmaceutical
A state-of-the-art facility in King of business manufactures healthcare, pharma- well,” he revealed. very focused on the pharmaceutical busi- and biotech,” he concluded.
Prussia, Pennsylvania, USA, is helping ceutical and life science products, and
ensure supply chain continuity and fl exi- ion exchange, catalyst, adsorbent and EXCIPIENT INNOVATION
bility for pharma and life-science indus- specialty resins for water and non-water
try customers globally for diversifi ed applications. Headquartered in King of Nordic Bioproducts Group highlights sustainability
conglomerate, Ecolab, according to Prussia, Purolite has manufacturing faci-
Mr. Shaq Pan, SVP & GM- Global Puro- lities in the US, UK, China and Romania. and purity of its microcrystalline cellulose offering
lite Industrial.
In the pharma and medical sector, Finnish biotech company, Nordic The company, founded in 2019 them to produce a very pure form of
Ecolab is a leading global provider of Purolite Resins provide solutions for a Bioproducts Group (NBG), put the as a spin-off from Aalto University MCC.
water, hygiene and infection prevention range of applications. The resins are used spotlight on its microcrystalline cellu- (Finland), has developed a proprietary
solutions and services, while its Purolite Mr. Shaq Pan in drug formulations as active pharma- lose (MCC) portfolio at CPHI Milan. technology, AaltoCell, that enables “With AaltoCell technology, we are

182 Chemical Weekly November 19, 2024 Chemical Weekly November 19, 2024 183

Contents Index to Advertisers Index to Products Advertised